Month: April 2022

Atlantica to Present First Quarter 2022 Financial Results on May 9

Written by Customer Service on April 29, 2022. Posted in Public Companies.

April 29, 2022 – Atlantica Sustainable Infrastructure (NASDAQ: AY) announced today that it will release its financial results for the first quarter of 2022 before the opening of the market on Monday, May 9, 2022. The information will be published on Atlantica’s website www.atlantica.com. Atlantica’s CEO, Santiago Seage and CFO, Francisco Martinez-Davis, will hold a conference call and a webcast on Monday, May 9, 2022, at 8:15 am (New York time). Additionally, the senior management team will hold meetings with investors on May 11, at the Citi 2022 Global Energy, Utilities and Climate Technology Conference in Boston, on May 12, at the Credit Suisse 2022 Renewables and Utilities Conference in New York and on May 16, 2022, at the EIC 2022 Investor Conference in Florida. A live webcast of the conference call will also be available on Atlantica’s...

Deep Learning Chip Market – Technology & Vendor Assessment (Vendor Summary Profiles, Strategies, Capabilities & Product Mapping & Regional Economic Analysis) by MDC Research

Written by Customer Service on April 29, 2022. Posted in Mergers And Acquisitions.

During the projection period of 2022–2030, the global deep learning chip market is expected to reach USD 83234.5 million, growing at a CAGR of 36.2%. Pune, April 29, 2022 (GLOBE NEWSWIRE) — The market for deep learning chips is growing at a breakneck speed. Over the study period, the worldwide deep learning chip market is predicted to be fueled by the introduction of quantum computing and growing deep learning applications such as autonomous cars, smart homes, smart cities, and robots. The global deep learning chip market is driven by the growing number of AI applications, improved processing power, and growing deep learning and neural networks across all key industries. Deep learning neural networks are composed of three or more layers that help machines perform predictive modeling and use large datasets to make informed decisions....

Kering: 2022 ANNUAL GENERAL MEETING: APPROVAL OF ALL RESOLUTIONS AND CHANGES IN THE MEMBERSHIP OF KERING’S BOARD OF DIRECTORS

Written by Customer Service on April 29, 2022. Posted in Public Companies.

PRESS RELEASE April 29, 20222022 ANNUAL GENERAL MEETING: APPROVAL OF ALL RESOLUTIONS AND CHANGES IN THE MEMBERSHIP OF KERING’S BOARD OF DIRECTORS Kering’s Combined General Meeting was held on April 28, 2022 at the Group’s headquarters, 40 rue de Sèvres, Paris 7e, France. Kering’s shareholders approved all the resolutions submitted for their vote, including those related to the membership of the Board of Directors. Yonca Dervisoglu, Véronique Weill and Serge Weinberg have been appointed as Independent Directors and the term of office of Daniela Riccardi as Independent Director has been renewed. Consequently, Kering’s Board of Directors comprises 14 members and includes:7 Independent Directors (i.e., a rate of 58% excluding Directors representing employees, in accordance with the provisions of the AFEP-MEDEF Code); 6...

Vitrectomy Devices Market – Technology & Vendor Assessment (Vendor Summary Profiles, Strategies, Capabilities & Product Mapping & Regional Economic Analysis) by MDC Research

Written by Customer Service on April 29, 2022. Posted in Mergers And Acquisitions.

The global vitrectomy devices market will reach an estimated value of ~USD 2,180 million by 2030, growing at a CAGR of ~7.3% between 2022 and 2030. Pune, April 29, 2022 (GLOBE NEWSWIRE) — Vitrectomy devices are necessary medical accessories and tools for the procedure. Vitrectomy is a type of eye surgery used to correct problems in the vitreous and retina. The most common symptoms of eye problems are seeing floating cobwebs or specks, distorted or blurred vision, side vision issues, and loss of vision. During surgery, the surgeon removes the vitreous and replaces it with a different solution. ? The center of the eye is filled with vitreous, which is a gel-like substance. Vitrectomy surgery requires the use of specialized equipment, such as Vitrectomy supplies and systems. Vitrectomy machines, tamponades, scissors, light pipes,...

A/S Øresund Notice of Extraordinary General Meeting

Written by Customer Service on April 29, 2022. Posted in Public Companies.

A/S Øresund Notice of Extraordinary General Meeting

A/S Storebælt Notice of Extraordinary General Meeting

Written by Customer Service on April 29, 2022. Posted in Public Companies.

A/S Storebælt Notice of Extraordinary General MeetingAttachment2022 EGF Indkaldelse – AS Storebælt UK

Compagnie Financière Tradition: Annual Report 2021 of Compagnie Financière Tradition SA

Written by Customer Service on April 29, 2022. Posted in Earnings Releases And Operating Results.

Ad hoc announcement pursuant to Article 53 of the Six ExchangeRegulation Listing Rules Lausanne, 29 April 2022Annual Report 2021of Compagnie Financière Tradition SA The Annual Report and Accounts 2021 of Compagnie Financière Tradition SA is available on the Company’s website at http://www.tradition.com/financials/reports.aspx Compagnie Financière Tradition’s annual general meeting will be held on Thursday, 24 May 2022 at 3.30 pm at the Hotel Beau-Rivage Palace, Lausanne. Notice of the meeting with the agenda and proposals of the Board of Directors is published on 29 April 2022 in the “FOSC”, and is also available on the Company’s website at https://www.tradition.com/financials/press-releases/2022.aspx For information and subject to approval of the General meeting of shareholders, Compagnie Financière Tradition SA...

BE Semiconductor Industries N.V. Announces Q1-22 Results

Written by Customer Service on April 29, 2022. Posted in Earnings Releases And Operating Results.

Q1-22 Revenue of € 202.4 Million and Net Income of € 67.5 Million Up 41.3% and 79.5%, Respectively, vs. Q1-21Orders of € 204.8 Million Include Follow-On Hybrid Bonding OrdersQuarterly Share Repurchases Increased from € 15 to € 25 Million DUIVEN, The Netherlands, April 29, 2022 (GLOBE NEWSWIRE) — BE Semiconductor Industries N.V. (the “Company” or “Besi”) (Euronext Amsterdam: BESI; OTC markets: BESIY), a leading manufacturer of assembly equipment for the semiconductor industry, today announced its results for the first quarter ended March 31, 2022. Key HighlightsRevenue of € 202.4 million, up 17.9% vs. Q4-21 primarily due to increased shipments for HPC applications including datacenter, advanced logic and hybrid bonding. At high end of prior guidance. Up 41.3% vs. Q1-21 due to increased demand for HPC and automotive...

Novo Nordisk’s sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022

Written by Customer Service on April 29, 2022. Posted in Earnings Releases And Operating Results.

Financial report for the period 1 January 2022 to 31 March 2022 Operating profit increased by 28% in Danish kroner and by 18% at constant exchange rates (CER) to DKK 19.1 billion. Sales in International Operations increased by 18% in Danish kroner (13% at CER), and sales in North America Operations increased by 33% in Danish kroner (24% at CER). Sales within Diabetes and Obesity care increased by 27% in Danish kroner to DKK 36.7 billion (20% at CER), mainly driven by GLP-1 diabetes sales growth of 54% in Danish kroner (45% at CER). Rare disease sales increased by 8% measured in Danish kroner (3% at CER). Obesity care sales grew 119% in Danish Kroner (107% at CER) driven by Wegovy® sales...

Novo Nordisk’s sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022

Written by Customer Service on April 29, 2022. Posted in Earnings Releases And Operating Results.

Financial report for the period 1 January 2022 to 31 March 2022Operating profit increased by 28% in Danish kroner and by 18% at constant exchange rates (CER) to DKK 19.1 billion. Sales in International Operations increased by 18% in Danish kroner (13% at CER), and sales in North America Operations increased by 33% in Danish kroner (24% at CER). Sales within Diabetes and Obesity care increased by 27% in Danish kroner to DKK 36.7 billion (20% at CER), mainly driven by GLP-1 diabetes sales growth of 54% in Danish kroner (45% at CER). Rare disease sales increased by 8% measured in Danish kroner (3% at CER). Obesity care sales grew 119% in Danish Kroner (107% at CER) driven by Wegovy® sales of DKK 1.4 billion. The contract manufacturer filling syringes for Wegovy® has reinitiated commercial production and Novo Nordisk expects to make all...

Month: April 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals